Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease

Bong Geom Jang, Sang Moon Yun, Kyungsook Ahn, Ju Hee Song, Sangmee A. Jo, Young Yul Kim, Doh Kwan Kim, Moon Ho Park, Changsu Han, Young Ho Koh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Carbonic anhydrase (CA) plays a critical role in pH regulation, long-term synaptic transformation, and is associated with mental retardation, Alzheimer's disease (AD), and Down syndrome. There is accumulating evidence that CAII is increased in AD brain. The present study focused on the determination of CAII protein level in blood plasma samples using immunoblot and ELISA methods. We compared plasma from 91 AD patients (average age 74.8 y), 83 persons with amnestic mild cognitive impairment (MCI) (average age 73.7 y), and 113 cognitively normal controls (average age 70.8 y). The plasma level of CAII was significantly increased in AD patients, as compared to control groups. CAII levels were higher in males than females. There was an age-dependent increase of CAII. These results provide further evidence that changes in CAII level may play a role in the pathogenesis of AD.

Original languageEnglish
Pages (from-to)939-945
Number of pages7
JournalJournal of Alzheimer's Disease
Volume21
Issue number3
DOIs
Publication statusPublished - 2010 Oct 6

Fingerprint

Carbonic Anhydrase II
Alzheimer Disease
Proteins
Carbonic Anhydrases
Down Syndrome
Intellectual Disability
Enzyme-Linked Immunosorbent Assay
Control Groups
Brain

Keywords

  • Alzheimer's disease
  • carbonic anhydrase II
  • mild cognitive impairment
  • plasma

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Jang, B. G., Yun, S. M., Ahn, K., Song, J. H., Jo, S. A., Kim, Y. Y., ... Koh, Y. H. (2010). Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease. Journal of Alzheimer's Disease, 21(3), 939-945. https://doi.org/10.3233/JAD-2010-100384

Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease. / Jang, Bong Geom; Yun, Sang Moon; Ahn, Kyungsook; Song, Ju Hee; Jo, Sangmee A.; Kim, Young Yul; Kim, Doh Kwan; Park, Moon Ho; Han, Changsu; Koh, Young Ho.

In: Journal of Alzheimer's Disease, Vol. 21, No. 3, 06.10.2010, p. 939-945.

Research output: Contribution to journalArticle

Jang, BG, Yun, SM, Ahn, K, Song, JH, Jo, SA, Kim, YY, Kim, DK, Park, MH, Han, C & Koh, YH 2010, 'Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease', Journal of Alzheimer's Disease, vol. 21, no. 3, pp. 939-945. https://doi.org/10.3233/JAD-2010-100384
Jang, Bong Geom ; Yun, Sang Moon ; Ahn, Kyungsook ; Song, Ju Hee ; Jo, Sangmee A. ; Kim, Young Yul ; Kim, Doh Kwan ; Park, Moon Ho ; Han, Changsu ; Koh, Young Ho. / Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease. In: Journal of Alzheimer's Disease. 2010 ; Vol. 21, No. 3. pp. 939-945.
@article{3825204a4fef49b492a376f476a77b29,
title = "Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease",
abstract = "Carbonic anhydrase (CA) plays a critical role in pH regulation, long-term synaptic transformation, and is associated with mental retardation, Alzheimer's disease (AD), and Down syndrome. There is accumulating evidence that CAII is increased in AD brain. The present study focused on the determination of CAII protein level in blood plasma samples using immunoblot and ELISA methods. We compared plasma from 91 AD patients (average age 74.8 y), 83 persons with amnestic mild cognitive impairment (MCI) (average age 73.7 y), and 113 cognitively normal controls (average age 70.8 y). The plasma level of CAII was significantly increased in AD patients, as compared to control groups. CAII levels were higher in males than females. There was an age-dependent increase of CAII. These results provide further evidence that changes in CAII level may play a role in the pathogenesis of AD.",
keywords = "Alzheimer's disease, carbonic anhydrase II, mild cognitive impairment, plasma",
author = "Jang, {Bong Geom} and Yun, {Sang Moon} and Kyungsook Ahn and Song, {Ju Hee} and Jo, {Sangmee A.} and Kim, {Young Yul} and Kim, {Doh Kwan} and Park, {Moon Ho} and Changsu Han and Koh, {Young Ho}",
year = "2010",
month = "10",
day = "6",
doi = "10.3233/JAD-2010-100384",
language = "English",
volume = "21",
pages = "939--945",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Plasma carbonic anhydrase II protein is elevated in Alzheimer's disease

AU - Jang, Bong Geom

AU - Yun, Sang Moon

AU - Ahn, Kyungsook

AU - Song, Ju Hee

AU - Jo, Sangmee A.

AU - Kim, Young Yul

AU - Kim, Doh Kwan

AU - Park, Moon Ho

AU - Han, Changsu

AU - Koh, Young Ho

PY - 2010/10/6

Y1 - 2010/10/6

N2 - Carbonic anhydrase (CA) plays a critical role in pH regulation, long-term synaptic transformation, and is associated with mental retardation, Alzheimer's disease (AD), and Down syndrome. There is accumulating evidence that CAII is increased in AD brain. The present study focused on the determination of CAII protein level in blood plasma samples using immunoblot and ELISA methods. We compared plasma from 91 AD patients (average age 74.8 y), 83 persons with amnestic mild cognitive impairment (MCI) (average age 73.7 y), and 113 cognitively normal controls (average age 70.8 y). The plasma level of CAII was significantly increased in AD patients, as compared to control groups. CAII levels were higher in males than females. There was an age-dependent increase of CAII. These results provide further evidence that changes in CAII level may play a role in the pathogenesis of AD.

AB - Carbonic anhydrase (CA) plays a critical role in pH regulation, long-term synaptic transformation, and is associated with mental retardation, Alzheimer's disease (AD), and Down syndrome. There is accumulating evidence that CAII is increased in AD brain. The present study focused on the determination of CAII protein level in blood plasma samples using immunoblot and ELISA methods. We compared plasma from 91 AD patients (average age 74.8 y), 83 persons with amnestic mild cognitive impairment (MCI) (average age 73.7 y), and 113 cognitively normal controls (average age 70.8 y). The plasma level of CAII was significantly increased in AD patients, as compared to control groups. CAII levels were higher in males than females. There was an age-dependent increase of CAII. These results provide further evidence that changes in CAII level may play a role in the pathogenesis of AD.

KW - Alzheimer's disease

KW - carbonic anhydrase II

KW - mild cognitive impairment

KW - plasma

UR - http://www.scopus.com/inward/record.url?scp=77957272701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957272701&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-100384

DO - 10.3233/JAD-2010-100384

M3 - Article

VL - 21

SP - 939

EP - 945

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -